Matthew Hamilton Rosenberg’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.3K Hold
1,330
0.01% 515
2026
Q1
$29.3K Hold
1,330
0.01% 497
2025
Q4
$15.7K Hold
1,330
﹤0.01% 574
2025
Q3
$21.1K Hold
1,330
﹤0.01% 534
2025
Q2
$15.2K Hold
1,330
﹤0.01% 603
2025
Q1
$18K Hold
1,330
﹤0.01% 549
2024
Q4
$22.5K Sell
1,330
-450
-25% -$8.76K 0.01% 523
2024
Q3
$36.2K Hold
1,780
0.01% 478
2024
Q2
$40.3K Hold
1,780
0.01% 456
2024
Q1
$51.2K Hold
1,780
0.01% 431
2023
Q4
$56.1K Hold
1,780
0.02% 412
2023
Q3
$49.9K Hold
1,780
0.02% 420
2023
Q2
$65.7K Hold
1,780
0.02% 382
2023
Q1
$53.3K Hold
1,780
0.02% 449
2022
Q4
$54.5K Hold
1,780
0.02% 436
2022
Q3
$44K Hold
1,780
0.02% 469
2022
Q2
$56K Hold
1,780
0.02% 418
2022
Q1
$56K Hold
1,780
0.02% 435
2021
Q4
$60K Hold
1,780
0.02% 386
2021
Q3
$52K Hold
1,780
0.02% 384
2021
Q2
$62K Sell
1,780
-410
-19% -$13.6K 0.03% 330
2021
Q1
$61K Hold
2,190
0.03% 323
2020
Q4
$54K Buy
2,190
+12
+0.6% +$286 0.03% 322
2020
Q3
$46K Hold
2,178
0.03% 315
2020
Q2
$33K Buy
+2,178
New +$27.5K 0.03% 354

Other funds holding CC

Matthew Hamilton Rosenberg's CC Position: Q2 2026 in Review

Matthew Hamilton Rosenberg held its Chemours (CC) position steady in Q2 2026 at 1,330 shares worth $27.3K. The position accounts for 0.01% of the portfolio, ranked #515.

Matthew Hamilton Rosenberg first reported a position in CC in Q2 2020 and has held it in 25 quarters since. The position peaked at $65.7K in Q2 2023. 469 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Matthew Hamilton Rosenberg held 1,330 shares of Chemours worth $27.3K as of Q2 2026.
  • Matthew Hamilton Rosenberg left its Chemours share count unchanged in Q2 2026.
  • Chemours made up 0.01% of Matthew Hamilton Rosenberg's portfolio in Q2 2026, its #515 holding.
  • Matthew Hamilton Rosenberg first reported a position in Chemours in Q2 2020 and has held it in 25 quarters since.
  • Matthew Hamilton Rosenberg's Chemours position peaked at $65.7K in Q2 2023.
  • 469 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Matthew Hamilton Rosenberg's 13F filing for Q2 2026, filed 17 Jul 2026.